about
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateDendritic cell vaccines for brain tumorsMolecular determinants of the response of glioblastomas to EGFR kinase inhibitors.Imaging biomarkers for antiangiogenic therapy in malignant gliomas.pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRISimulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T.Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients.The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cellsBioluminescent imaging of melanoma in live miceCellular and vaccine therapeutic approaches for gliomasRecurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas.Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence.Radial mobility and cytotoxic function of retroviral replicating vector transduced, non-adherent alloresponsive T lymphocytes.A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.Genomic landscape of meningiomas.Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cellsRibosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitorsBone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastomaQuantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapyPD-1 blockade enhances the vaccination-induced immune response in gliomaEssential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence.Current status of clinical trials for glioblastoma.Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange.Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage.Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma.An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicityEarly experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.Large-scale assessment of the gliomasphere model systemIncidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma.C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma.BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles.Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden.
P50
Q24320239-66576897-0B0E-4ECB-A7AD-223E48A3DF43Q24641823-6B66C720-CA9C-4BFF-B9E5-E2D597C2D585Q27824850-F8CE8415-F9A4-45B7-88BF-3E4E6A54E7E0Q30764736-50E2E604-96B6-4F04-8049-B29C7DB73319Q30976860-984CADD7-8B7C-41F4-88F7-A47F6B3F9A9EQ31135567-A38FB167-6874-48E0-A779-1AD0D3EF9ECCQ33616632-28CCFD6B-DED9-42CA-92FC-4B025F9EEC76Q33691858-D1AC17D7-AEF7-477B-BB71-4C7F9D40F698Q33928765-47189F50-2BC6-4B16-B3BB-A1877DC61DACQ34077913-1028D5BE-0F24-4FF7-99CB-A80BB61D930AQ34243550-607ACDB7-24AF-48F0-B1CA-112406D324B8Q34324645-953D8955-BCBD-4054-8E65-B41C143E165DQ34518462-CEC6492C-C95E-4D3C-A2FD-90546B06E8C7Q35048997-D494F761-EDC7-480C-9768-3DFB2431C676Q35162225-472DB56C-518E-41B3-B6A7-FBA8B4A53DD7Q35186717-4DE17BB7-05C1-46F9-BF32-91705AA52D6CQ35197844-7C9BFA09-C8ED-4E77-9530-90A2E5B23A03Q35609699-3C93A03A-04C8-4603-AF5C-37F0FFD1953AQ35631598-37F968A5-F63E-4DEE-87B0-71DA950ABD54Q35823287-02E5FCF9-F1D2-4507-A3E2-828DC2E10BADQ35967385-F7A0ED36-A9CD-47FF-AA03-8AF7B85FBFE0Q36259173-31598A6C-4936-4641-B53C-1FFFA793D49AQ36486875-D7672953-A8F7-4705-820C-C8C73514427FQ36500377-0A2B8148-AEC4-4829-B8B9-207565F9080FQ36618229-57634493-CA60-4BBB-8DAA-4F8F749A9150Q36627187-FCB23746-328F-43C3-BD0E-ABC28505F73CQ37109193-4A92A1AA-B4DE-41F6-B6A8-10F4DABAF3D5Q37132697-1C1B8D62-C5F4-4410-8DFE-3C9B80E0957DQ37161208-4C41B8A5-B8EA-4A39-8EB2-6D2FC4AB4D78Q37172332-3AB75A67-2B2B-471F-8FEE-BCAF30DAF085Q37456820-03B69A92-5976-4661-BD55-9FA642A749AEQ37571743-00AE5482-89C4-49D9-9852-16CEF522AF46Q37573880-2B4F50BB-845F-4454-BC13-D389DF82EA3EQ38701815-9CEEB13E-F9FB-42E8-A132-A271C8722051Q38875547-A3B7AD62-E2EB-4CEB-887E-C31CBA3084CBQ38978686-5AA31CF2-3042-41EB-93AC-4FEC7A1261CAQ39003387-5970AA4C-43DF-4E7B-AADB-83018C859BE1Q39029492-B0FD4734-178F-4C87-98DE-E9D3A3E9E715Q40126434-D1AB5AF7-1526-493D-9540-6D9E0799293CQ40335222-5E0EDF8A-AD22-4F7E-81B8-4434399593D1
P50
description
American neuroscientist
@en
wetenschapper
@nl
name
Linda Liau
@ast
Linda Liau
@en
Linda Liau
@es
Linda Liau
@nl
type
label
Linda Liau
@ast
Linda Liau
@en
Linda Liau
@es
Linda Liau
@nl
altLabel
Linda M. Liau
@en
prefLabel
Linda Liau
@ast
Linda Liau
@en
Linda Liau
@es
Linda Liau
@nl
P214
P244
P106
P1960
bDpdeJIAAAAJ
P21
P213
0000 0000 2286 1398
P214
P244
P31
P496
0000-0002-4053-0052
P735
P7859
lccn-n00121970